Abstract
This study of 24 gynecologic neoplasms was initiated with the hope that tumor localization of 67Ga might prove to be clinically useful to: (1) serve as a screening device for the diagnosis of some primary gynecologic tumors or their recurrences; (2) demonstrate the presence of local or distant metastasis; and (3) facilitate clinical judgment regarding operability of certain lesions. At the present time, with the use of available techniques, our preliminary observations suggest that 67Ga scintigraphy has not reliably delineated the distribution of the various gynecologic malignancies studies. Thus, 67Ga does not appear to provide a satisfactory clinical method for determining the presence of metastasis or the operability of specific patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
